"Ropren® may be considered the flagship product of Solagran. However, it is quite
possible that in years to come, sales other forms of Bioeffective® R (including the
liposomal, injectable and nano-particle formats that have already been
developed) and even Bioeffective® A, may surpass those of Ropren®."
RM Research report
- Forums
- ASX - By Stock
- SLA
- bioeffective a
bioeffective a, page-2
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online